Author Details

Dyakonova, Yu. Yu.

Issue Section Title File
Vol 16, No 4 (2017) Статьи Blinatumomab therapy for relapsed and refractory acute lymphoblastic leukemia PDF
(Rus)
Vol 16, No 3 (2017) Статьи The results of pilot trial ALL-REZ-MВ-2014 for children with relapsed acute lymphoblastic leukemia PDF
(Rus)
Vol 14, No 2 (2015) ЛИМФОМЫ Brentuximab vedotin in therapy of a patient with refractory Hodgkin’s lymphoma and Proteus syndrome PDF
(Rus)
Vol 14, No 2 (2015) ЛИМФОМЫ Cerebral venous sinus thrombosis and bleeding in the brain in a patient with lymphoblastic lymphoma PDF
(Rus)
Vol 18, No 1 (2019) PROMISING STUDIES First results of pilot protocol ALl-REZ-2016 for children with high risk groups of relapsed acute lymphoblastic leukemia PDF
(Rus)
Vol 18, No 1 (2019) ORIGINAL ARTICLES Efficacy and toxicity of the treatment of children and adolescents with Hodgkin Lymphoma by GPOH-HD-2002 protocol PDF
(Rus)
Vol 18, No 1 (2019) CLINICAL OBSERVATIONS B-cell lymphoma is unclassifiable, with signs intermediate between diffuse large-cell B-cell lymphoma and Hodgkin lymphoma PDF
(Rus)
Vol 20, No 3 (2021) ORIGINAL ARTICLES Incidence of venous thromboembolism in children with primary lymphomas PDF
(Rus)
Vol 22, No 1 (2023) ORIGINAL ARTICLES Treatment of lymphoid malignancies in patients with primary immunodeficiencies associated with DNA repair defects PDF
(Rus)
Vol 22, No 1 (2023) ORIGINAL ARTICLES The use of inotuzumab ozogamicin in children with relapsed/refractory B-lineage acute lymphoblastic leukemia PDF
(Rus)
Vol 22, No 1 (2023) ORIGINAL ARTICLES The role of blinatumomab in the treatment of B-cell relapses of acute lymphoblastic leukemia in children: own experience PDF
(Rus)